ISDS Case Map
intellectual property
With the World Trade talks in limbo, the focus remains on aggressively pushing on the bilateral front. What could not be achieved through a multilateral trade regime, is now being pursued by the US through bilateral and regional deals. Devinder Sharma connects the dots.
The American-Malaysian Chamber of Commerce (AMCHAM Malaysia) Thursday refuted press reports that the US Free Trade Agreements (FTAs) in Chile and Singapore seeks to extend patents for 30 to 40 years through TRIPS-Plus.
The controversy over the impact of bilateral trade agreements on public health poses particular difficulties for the Geneva-based WHO, which is gearing up for the highly political election of a new director-general.
The agreement signed between the two governments will facilitate exchanges of information and scientists and technicians providing training to improve professional skills and the protection of intellectual property rights.
Malaysian manufacturers are wary of any move by the US to incorporate software patents and pharmaceutical patents in ongoing Free Trade Agreement (FTA) talks between the US and Malaysia.
In the midst of the world's biggest HIV/AIDS conference here, close to a hundred activists launched a noisy protest over bilateral free trade agreements, which they say elevate patent protections above the right to life-extending antiretroviral drugs.
Patent and data protection rules in free trade agreements have a profound
impact on the ability of developing countries to access life saving
medicines of assured quality.
Ukrit Kungsawanich, a fruit grower in Rayong, was worried when he read in the news that a US company is trying to patent a drink made with mangosteen extract.
Australia, which is keen to tie up a free trade agreement (FTA) with Asean) by the end of 2007, wants the services sector and protection of intellectual property (IP) be given top priority in the trade pact.
This examines macro-economic issues, intellectual property and patent protections, the potential impact on pharmaceuticals, and other issues at stake in the U.S.-Korea FTA.
